Article Text

Download PDFPDF

5PSQ-144 Medication reconciliation programme performed in a general and digestive surgery service
  1. C Mondelo-Garcia,
  2. JM Gutiérrez Urbón,
  3. L Margusino Framiñán,
  4. MI Martín Herranz
  1. Instituto de Investigación Biomédica de A Coruña Inibic. Complexo Hospitalario Universitario A Coruña Chuac. Sergas. Universidade da Coruña UDC., Pharmacy Service, A Coruña, Spain


Background Care transitions are critical points regarding medications errors because of the high number of treatment modifications that are carried out. Medication reconciliation (MR) and providing accurate information to the patients about their treatment can help prevent medication errors and consequently improve quality of care.

Purpose Our objective was to analyse discrepancies found between patients’ current medication and treatments prescribed during hospitalisation to reduce these through the intervention of the hospital pharmacist.

Material and methods Prospective study from 1 June to 1 October 2018. Patients admitted to the General and Digestive Surgery Service of a university hospital during the study period who met all the inclusion criteria (>65 years’ old and >4 current medications as home treatment). At admission, the hospital pharmacist reviewed the patient’s electronic medical records and interviewed the patient or the primary caregiver to obtain the accurate list of current medication. The hospital pharmacist contacted the physician to solve discrepancies which were classified in: omission, duplicity, wrong dose and wrong pharmaceutical form. Medications involved were classified according to the ATC classification. Patients who accepted, received written information about their treatment at discharge and answered a satisfaction survey. This study has been approved by the regional clinical research ethics committee.

Results Patients included: 127, 65 males (51.2%). Median age (range):80.1 (66.0–93.3). Mean hospitalisation time ±SD: 11.7±9.5 days. Median of medicines number as home treatment/patient (range): 7 (5–14). Median of discrepancies found at admission/patient (range): 2 (0–4): 10 patients (7.9%) did not present any discrepancy. Discrepancies classification (n=214): 196 omission (91.6%), 14 wrong dose (6.5%), three wrong pharmaceutical forms (1.4%) and one duplicate (0.5%). Discrepancies solved: 108 (50.8%). Among 106 unsolved discrepancies, 47 (44.3%) were omissions of lipid-lowering agents in primary prevention which were not usually prescribed during admission. Main ATC group with discrepancies: 116 cardiovascular system medications (54.2%), followed by 25 of the nervous system (11.7%). Satisfaction survey evaluation (67 patients): 8.6/10 points.

Conclusion MR is an is an effective measure to reduce medication discrepancies. Hospital pharmacist intervention identified discrepancies, improving the quality of prescription during admission. Most unsolved discrepancies were statins in primary prevention. Cardiovascular and nervous system were the ATC groups with the most discrepancies. Patients report a high satisfaction rate.

References and/or acknowledgements This study has been carried out with the support of Fundación Profesor Novoa Santos.

No conflict of interest.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.